Process View
Any process that modulates the frequency, rate or extent of oxidoreductase activity, the catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of oxidoreductase activity"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
Lepr | leptin receptor | 0.432 | ||
Pten | phosphatase and tensin homolog | 0.336 | ||
Nos3 | nitric oxide synthase 3, endothelial cell | 0.319 | ||
Itgb1 | integrin beta 1 (fibronectin receptor beta) | 0.179 | ||
Lyz2 | lysozyme 2 | 0.138 | ||
Trp53 | transformation related protein 53 | 0.123 | ||
Tgfbr1 | transforming growth factor, beta receptor I | 0.104 | ||
Tnf | tumor necrosis factor | 0.102 | ||
Ctnnb1 | catenin (cadherin associated protein), beta 1 | 0.089 | ||
Tgfbr2 | transforming growth factor, beta receptor II | 0.085 | ||
Casp4 | caspase 4, apoptosis-related cysteine peptidase | 0.073 | ||
Fas | Fas (TNF receptor superfamily member 6) | 0.061 | ||
Tnfrsf1a | tumor necrosis factor receptor superfamily, member 1a | 0.060 | ||
Cd44 | CD44 antigen | 0.059 | ||
Tlr4 | toll-like receptor 4 | 0.059 | ||
Notch2 | Notch gene homolog 2 (Drosophila) | 0.053 | ||
Vegfa | vascular endothelial growth factor A | 0.050 | ||
Src | Rous sarcoma oncogene | 0.049 | ||
Pparg | peroxisome proliferator activated receptor gamma | 0.048 | Mouse | |
Ric8 | resistance to inhibitors of cholinesterase 8 homolog (C. elegans) | 0.048 | ||
Pycard | PYD and CARD domain containing | 0.047 | ||
Apoe | apolipoprotein E | 0.047 | Human | |
Map3k8 | mitogen-activated protein kinase kinase kinase 8 | 0.042 | ||
Relb | avian reticuloendotheliosis viral (v-rel) oncogene related B | 0.042 | ||
Casp1 | caspase 1 | 0.042 | ||
Rxra | retinoid X receptor alpha | 0.042 | ||
Tlr2 | toll-like receptor 2 | 0.042 | ||
Tgfb1 | transforming growth factor, beta 1 | 0.041 | ||
Traf6 | TNF receptor-associated factor 6 | 0.040 | ||
Ptgs2 | prostaglandin-endoperoxide synthase 2 | 0.037 | ||
Plau | plasminogen activator, urokinase | 0.035 | ||
Il1r1 | interleukin 1 receptor, type I | 0.035 | ||
Ppargc1a | peroxisome proliferative activated receptor, gamma, coactivator 1 alpha | 0.033 | ||
Tnfaip3 | tumor necrosis factor, alpha-induced protein 3 | 0.033 | ||
Wt1 | Wilms tumor 1 homolog | 0.031 | ||
Map3k14 | mitogen-activated protein kinase kinase kinase 14 | 0.031 | ||
Hif1a | hypoxia inducible factor 1, alpha subunit | 0.030 | ||
Agtr1a | angiotensin II receptor, type 1a | 0.029 | Mouse | |
Pcdh12 | protocadherin 12 | 0.028 | ||
Grin1 | glutamate receptor, ionotropic, NMDA1 (zeta 1) | 0.028 | ||
Smad4 | MAD homolog 4 (Drosophila) | 0.026 | ||
Lep | leptin | 0.025 | ||
Nos1 | nitric oxide synthase 1, neuronal | 0.024 | ||
Ywhah | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.024 | ||
Agt | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 0.024 | ||
Nos2 | nitric oxide synthase 2, inducible | 0.023 | ||
Nfkbia | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.023 | ||
Lox | lysyl oxidase | 0.023 | ||
Csf1 | colony stimulating factor 1 (macrophage) | 0.022 | ||
Bdkrb2 | bradykinin receptor, beta 2 | 0.022 | Mouse | |
Cdkn1b | cyclin-dependent kinase inhibitor 1B | 0.021 | ||
Agtrap | angiotensin II, type I receptor-associated protein | 0.021 | ||
Ptrf | polymerase I and transcript release factor | 0.020 | ||
Casp8 | caspase 8 | 0.020 | ||
Acvrl1 | activin A receptor, type II-like 1 | 0.020 | ||
Nfkb2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 | 0.020 | ||
Nfe2l2 | nuclear factor, erythroid derived 2, like 2 | 0.019 | ||
Ren1 | renin 1 structural | 0.018 | ||
Hsd17b10 | hydroxysteroid (17-beta) dehydrogenase 10 | 0.018 | ||
Ifng | interferon gamma | 0.018 | ||
Ldlr | low density lipoprotein receptor | 0.017 | ||
Bcar1 | breast cancer anti-estrogen resistance 1 | 0.016 | ||
Cd40 | CD40 antigen | 0.016 | ||
Nr0b2 | nuclear receptor subfamily 0, group B, member 2 | 0.016 | ||
Egfr | epidermal growth factor receptor | 0.016 | ||
Insr | insulin receptor | 0.015 | ||
Efemp2 | epidermal growth factor-containing fibulin-like extracellular matrix protein 2 | 0.015 | ||
Npy1r | neuropeptide Y receptor Y1 | 0.015 | ||
Apoa1 | apolipoprotein A-I | 0.015 | ||
Myd88 | myeloid differentiation primary response gene 88 | 0.015 | ||
Col1a1 | collagen, type I, alpha 1 | 0.015 | ||
Lrp1 | low density lipoprotein receptor-related protein 1 | 0.015 | ||
Mstn | myostatin | 0.015 | ||
Dll4 | delta-like 4 (Drosophila) | 0.014 | ||
Cebpa | CCAAT/enhancer binding protein (C/EBP), alpha | 0.014 | ||
Dmd | dystrophin, muscular dystrophy | 0.014 | ||
Cav1 | caveolin 1, caveolae protein | 0.014 | ||
Ptpn11 | protein tyrosine phosphatase, non-receptor type 11 | 0.014 | ||
Clcn5 | chloride channel 5 | 0.014 | ||
Fbn1 | fibrillin 1 | 0.013 | ||
Plin1 | perilipin 1 | 0.013 | ||
Grhpr | glyoxylate reductase/hydroxypyruvate reductase | 0.013 | ||
Gna11 | guanine nucleotide binding protein, alpha 11 | 0.013 | ||
Il1a | interleukin 1 alpha | 0.013 | ||
En1 | engrailed 1 | 0.012 | ||
Nr3c1 | nuclear receptor subfamily 3, group C, member 1 | 0.012 | ||
Rbpjl | recombination signal binding protein for immunoglobulin kappa J region-like | 0.012 | ||
Smad2 | MAD homolog 2 (Drosophila) | 0.012 | ||
Lif | leukemia inhibitory factor | 0.012 | ||
Megf8 | multiple EGF-like-domains 8 | 0.012 | ||
Ces1d | carboxylesterase 1D | 0.012 | ||
Adcy4 | adenylate cyclase 4 | 0.012 | ||
Rag1 | recombination activating gene 1 | 0.012 | ||
Cyp4a14 | cytochrome P450, family 4, subfamily a, polypeptide 14 | 0.012 | ||
Ywhaz | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.012 | ||
Esr1 | estrogen receptor 1 (alpha) | 0.011 | Human | |
Il22 | interleukin 22 | 0.011 | ||
Gm3776 | predicted gene 3776 | 0.011 | ||
Tnfrsf11a | tumor necrosis factor receptor superfamily, member 11a | 0.011 | ||
Ace | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | 0.011 | ||
Apc | adenomatosis polyposis coli | 0.011 | ||
Psen1 | presenilin 1 | 0.011 | ||
Ly6d | lymphocyte antigen 6 complex, locus D | 0.011 | ||
Vhl | von Hippel-Lindau tumor suppressor | 0.011 | ||
Ednrb | endothelin receptor type B | 0.011 | ||
Cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 0.011 | ||
Il4ra | interleukin 4 receptor, alpha | 0.011 | ||
Nr3c2 | nuclear receptor subfamily 3, group C, member 2 | 0.011 | ||
Rela | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.011 | ||
Itgb1bp2 | integrin beta 1 binding protein 2 | 0.011 | ||
Arhgef7 | Rho guanine nucleotide exchange factor (GEF7) | 0.010 | ||
Mmp9 | matrix metallopeptidase 9 | 0.010 | ||
Ooep | oocyte expressed protein homolog (dog) | 0.010 | ||
Ret | ret proto-oncogene | 0.010 | ||
Tnfsf11 | tumor necrosis factor (ligand) superfamily, member 11 | 0.010 | ||
Cdkn2a | cyclin-dependent kinase inhibitor 2A | 0.010 | ||
Gstm1 | glutathione S-transferase, mu 1 | 0.010 |